Game-changing gift announced at inaugural Penn Africa Research Symposium The $5 million gift creates the Holman Africa Initiative, expanding financial aid and enhancing opportunities for faculty and students to engage in research and teaching in and on Africa. Ocek Eke, director of Global and Local Service-Learning Programs at Penn Engineering, speaks at the start of the Penn Africa Research Symposium.
A $5 million gift from Wendy and Wayne Holman will create a new initiative at Penn aimed at dramatically expanding financial aid and enhancing opportunities for faculty and students to engage in research and teaching in and about Africa.
The Holman Africa Initiative was announced at the start of the inaugural Penn Africa Research Symposium organized by Penn Global, which offered more than 40 participants from across the University an opportunity to virtually present their wide-ranging research on Africa during a three-hour event. The n
Antiviral pill shown to be effective in treating COVID-19 in phase 2 trial kbzk.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kbzk.com Daily Mail and Mail on Sunday newspapers.
Antiviral pill shown to be effective in treating COVID-19 in phase 2 trial
Seth Wenig/AP
Merck corporate headquarters is seen in Kenilworth, N.J., Tuesday, May 1, 2018. Drugmaker Merck s first-quarter revenue rose 6 percent, driven by a huge jump in sales of cancer blockbuster Keytruda, but a $1.4 billion charge for starting a research partnership with Japanese drugmaker Eisai dragged down profits by more than half. (AP Photo/Seth Wenig)
and last updated 2021-03-08 13:43:20-05
An antiviral pill has shown to be effective in treating COVID-19, according to Phase 2 trial results released late last week.
Should those promising results continue in large-scale Phase 3 trials, the drug could become vital in the fight against COVID-19 â a disease that still has few treatment options for those suffering from mild to moderate cases.
Could A COVID Pill Stop ‘The Virus In Its Tracks’?
03/08/21 AT 8:23 AM
A new experimental drug is being tested and shows promise of eliminating COVID-19 just by taking a pill.
The pill, Molnupiravir, which is being developed by Ridgeback Biotherapeutics and Merck (MRK), was found to reduce the virus in individuals after five days of treatment in a mid-stage study, the companies announced in a release on March 6.
While more studies of Molnupiravir are underway, the companies say the pill could provide a viable way to treat those that have symptoms of COVID-19 and be the first oral antiviral drug to combat the virus.